Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-02 19:20:20 - browse：41

Illustration of sound waves coming out of an ear and at the end of these waves we have a figure trying to push back against them and contain them. -- health coverage from STAT — Advances in gene therapy could eventually "cure" many forms of congenital deafness. The changes have many deaf people worried about the future of their communities. Eros Devishi for STAT

When Yilai Shu was training to be an otolaryngologist in Shanghai, in the mid 2000s, he often met parents with congenitally deaf kids.

“They always asked me, ‘Do you have any drugs to treat our kids?’ said Shu, who is hearing and a professor at Fudan University in China. “That’s what really inspired me to think about developing a drug.”

Decades later, Shu is closer than ever to such a drug. In October, he presented extraordinary data at a conference: His team had successfully enabled hearing in four congenitally deaf children using gene therapy. The work is the culmination of decades of genetic research and has spurred companies like Regeneron and Eli Lilly to swoop in and back other groups developing similar treatments.

The hearing gains are modest and the technology is currently limited to a type of deafness that only affects 1% to 8% of deaf people globally, but some experts suggest that gene therapy could eventually apply to as many as half of all congenitally deaf people. These treatments would have massive implications for the 12,000 kids born with hearing loss in the United States every year.

“This has been the dream of our field for 30-plus years to come up with a molecular treatment to give people real, natural hearing, that they were originally intended to have,” said Larry Lustig, a hearing otolaryngologist at Columbia University who is leading a Regeneron-backed trial showing promising results using gene therapy to treat deafness. “This is going to be transformative.”

But this transformative technology faces a problem: not all deaf people want it.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： A new ‘biological computer' targets cancer while sparing healthy cells

WSS

Caribou posts encouraging results on off

White House drug shortage group privately met with industry

There’s a way to spot data fakery. All journals should be using it

For BCIs, commercial hurdles may be bigger than scientific ones

Influencer to be charged after chaos erupts in New York City's Union Square

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

explore

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Telehealth startups are trying to fill the menopause care vacuum

Heart attack and stroke risk calculators need revising

After a decade, new Gardasil ad campaign gets it (mostly) right

Cancer drug shortages should be causing more outrage

White House drug shortage group privately met with industry

FDA approval of Sarepta Duchenne genetic therapy gives me hope

2 US Navy sailors arrested for allegedly spying for China

Cancer drug shortages should be causing more outrage

Mystery swirls around US soldier who entered North Korea days ago, officials say

entertainment

In rare move, senator releases unverified FBI source report alleging Biden bribe

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Judge denies Trump's request for new trial in E. Jean Carroll case

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

hotspot

entertainment

entertainment

hotspot